BILCARE LTD. (BI) financials

BILCARE LTD. (BI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Market Cap: ₹215Cr.
Current Price: ₹93.2
Stock P/E: 91.7
ROE: 0.01%
ROCE: 0.34%
Book Value: ₹179
Dividend Yield: 0.00%
52W High / Low: ₹116/50.0

In Jun 2026, BILCARE LTD. (BI) reported sales ₹1.94 Cr and net profit ₹1.04 Cr.

Annual TTM: sales ₹6.72 Cr, net profit ₹-1.56 Cr.

Shareholding: Promoters 30.01% (Jun 2026), FIIs 0.04% (Jun 2026), Public 69.94% (Jun 2026), No. of Shareholders 15,777% (Jun 2026).

BI quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2.76	3.36	4.13	2.07	1.85	1.73	1.20	1.94
Expenses	5.49	3.88	5.70	3.48	3.21	3.47	9.18	2.93
Operating Profit	-2.73	-0.52	-1.57	-1.41	-1.36	-1.74	-7.98	-0.99
OPM %	-98.91%	-15.48%	-38.01%	-68.12%	-73.51%	-100.58%	-665.00%	-51.03%
Other Income	3.78	3.78	6.45	6.72	3.45	5.46	1.74	2.62
Interest	3.04	0.12	0.06	0.14	0.17	0.15	0.14	0.12
Depreciation	0.77	0.77	0.60	0.68	0.72	0.71	0.61	0.60
Profit before tax	-2.76	2.37	4.22	4.49	1.20	2.86	-6.99	0.91
Tax %	-6.88%	23.63%	20.38%	20.04%	13.33%	5.24%	-9.16%	-14.29%
Net Profit	-2.57	1.81	3.36	3.59	1.04	2.71	-6.35	1.04
EPS in Rs	-1.09	0.77	1.43	1.52	0.44	1.15	-2.70	0.44
Raw PDF	—	—	—	—	—	—	—	—

BI profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	211.75	304.16	429.79	13.98	17.60	15.12	6.85	6.72
Expenses	219.34	279.00	393.05	21.12	26.71	20.80	19.34	18.79
Operating Profit	-7.59	25.16	36.74	-7.14	-9.11	-5.68	-12.49	-12.07
OPM %	-3.58%	8.27%	8.55%	-51.07%	-51.76%	-37.57%	-182.34%	-179.61%
Other Income	38.18	66.58	42.55	515.03	19.45	17.85	17.37	13.27
Interest	69.08	74.72	68.19	0.45	2.49	3.86	0.60	0.58
Depreciation	88.06	34.63	34.64	4.52	2.15	2.87	2.72	2.64
Profit before tax	-126.55	-17.61	-23.54	502.92	5.70	5.44	1.56	-2.02
Tax %	-19.15%	-110.11%	-24.47%	22.30%	6.32%	26.84%	36.54%	—
Net Profit	-102.32	1.78	-17.78	390.79	5.34	3.99	0.99	-1.56
EPS in Rs	-43.46	0.76	-7.55	165.97	2.27	1.69	0.42	-0.67
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

BI balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	23.55	23.55	23.55	23.55	23.55	23.55	23.55	23.55
Reserves	137.88	35.63	37.17	19.86	386.86	392.11	396.12	397.35
Borrowings	867.63	708.56	678.41	689.92	7.52	10.29	11.04	11.87
Other Liabilities	346.08	204.85	189.19	193.25	36.24	34.54	21.71	22.36
Total Liabilities	1,375.14	972.59	928.32	926.58	454.17	460.49	452.42	455.13
Fixed Assets	593.73	506.21	472.60	445.82	16.25	63.41	60.82	57.62
CWIP	0.28	0.00	0.08	0.00	0.00	0.00	0.00	0.00
Investments	513.37	173.17	89.49	80.51	293.51	293.52	293.52	309.71
Other Assets	267.76	293.21	366.15	400.25	144.41	103.56	98.08	87.80
Total Assets	1,375.14	972.59	928.32	926.58	454.17	460.49	452.42	455.13

BI cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	62.13	71.12	-0.41	46.29	397.43	97.63	2.36	11.57
Cash from Investing Activity	1.51	10.82	85.02	5.59	180.97	-107.06	2.94	-14.05
Cash from Financing Activity	-60.25	-83.03	-82.28	-55.47	-570.93	-0.51	-3.85	0.24
Net Cash Flow	3.39	-1.08	2.33	-3.59	7.47	-9.94	1.45	-2.24
Free Cash Flow	62.65	70.86	0.70	45.01	791.28	-10.14	4.98	13.70
CFO/OP	6,850%	-948%	-6%	129%	-5,581%	-1,065%	-21%	-105%

BI shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%
FIIs	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
Public	69.95%	69.95%	69.95%	69.95%	69.94%	69.95%	69.95%	69.94%
No. of Shareholders	18,241	18,496	17,586	17,047	16,513	16,068	15,824	15,777

BI key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	56.41	67.40	86.74	78.67	246.73	101.41	82.32	108.70
Inventory Days	68.40	56.55	85.32	71.21	60.10	21.27	30.02	37.12
Days Payable	155.62	128.77	116.24	100.16	439.03	91.35	154.06	435.11
Cash Conversion Cycle	-30.82	-4.82	55.82	49.72	-132.20	31.33	-41.72	-289.29
Working Capital Days	-395.82	-356.45	-178.42	-134.43	-640.97	1,135.23	1,530.01	2,541.15
ROCE %	-20.40%	-9.08%	0.34%	1.51%	-1.38%	-1.97%	1.58%	0.34%

BIUpdated 13 Oct 2026, 16:55

Bilcare Ltd.

BIUpdated 13 Oct 2026, 16:55

Market Cap

₹215Cr.

Current Price

₹93.2

High / Low

₹116/50.0

Stock P/E

91.7

ROE0.01%

ROCE0.34%

Book Value₹179

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	3.66	0.16	5.11	15.7	0.44	13.65	1.68	13.42	5.7
Sep 2023	4.59	0.08	6.64	-1.81	0.52	-4.46	-9.42	-4.04	-1.72
Dec 2023	5.06	0.19	6.28	0.33	0.56	-1.64	-5.49	-1.55	-0.66
Mar 2024	4.29	2.06	8.68	5.23	0.63	-1.85	34.59	-2.49	-1.06
Jun 2024	4.87	0.63	5.72	3.84	0.73	1.63	14.11	1.4	0.59
Sep 2024	2.76	3.04	5.49	3.78	0.77	-2.76	-6.88	-2.57	-1.09
Dec 2024	3.36	0.12	3.88	3.78	0.77	2.37	23.63	1.81	0.77
Mar 2025	4.13	0.06	5.7	6.45	0.6	4.22	20.38	3.36	1.43
Jun 2025	2.07	0.14	3.48	6.72	0.68	4.49	20.04	3.59	1.52
Sep 2025	1.85	0.17	3.21	3.45	0.72	1.2	13.33	1.04	0.44
Dec 2025	1.73	0.15	3.47	5.46	0.71	2.86	5.24	2.71	1.15
Mar 2026	1.2	0.14	9.18	1.74	0.61	-6.99	-9.16	-6.35	-2.7
Jun 2026	1.94	0.12	2.93	2.62	0.6	0.91	-14.29	1.04	0.44

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	331.33	131.84	310.3	4.36	105.52	-211.97	-13.35	-183.68	-78.01
Mar 2016	315.42	31.73	300.3	-105.57	101.29	-223.47	-65	-78.22	-33.22
Mar 2017	285.6	47.82	288.45	73.52	79.23	-56.38	16.94	-65.93	-28
Mar 2018	257.53	55.53	257.77	259.53	304.34	-100.58	-20.52	-79.94	-33.95
Mar 2019	239.81	72.1	238.89	5.59	248.47	-314.06	0.38	-315.25	-133.89
Mar 2020	211.75	69.08	219.34	38.18	88.06	-126.55	-19.15	-102.32	-43.46
Mar 2021	304.16	74.72	279	66.58	34.63	-17.61	-110.11	1.78	0.76
Mar 2022	429.79	68.19	393.05	42.55	34.64	-23.54	-24.47	-17.78	-7.55
Mar 2023	13.98	0.45	21.12	515.03	4.52	502.92	22.3	390.79	165.97
Mar 2024	17.6	2.49	26.71	19.45	2.15	5.7	6.32	5.34	2.27
Mar 2025	15.12	3.86	20.8	17.85	2.87	5.44	26.84	3.99	1.69
Mar 2026	6.85	0.6	19.34	17.37	2.72	1.56	36.54	0.99	0.42
TTM	6.72	0.58	18.79	13.27	2.64	-2.02	—	-1.56	-0.67

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	30.01%
FIIs	0.04%
Public	69.94%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	Public
Sep 2023	30.01%	0.04%	69.94%
Dec 2023	30.01%	0.04%	69.95%
Mar 2024	30.01%	0.04%	69.95%
Jun 2024	30.01%	0.04%	69.95%
Sep 2024	30.01%	0.04%	69.95%
Dec 2024	30.01%	0.04%	69.95%
Mar 2025	30.01%	0.04%	69.95%
Jun 2025	30.01%	0.04%	69.95%
Sep 2025	30.01%	0.04%	69.94%
Dec 2025	30.01%	0.04%	69.95%
Mar 2026	30.01%	0.04%	69.95%
Jun 2026	30.01%	0.04%	69.94%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	23.55	643.47	1151.44	802.28	2620.74	1217.32	124.66	682.43	596.33	2620.74
Mar 2016	23.55	598.97	975.7	441.11	2039.33	1176.79	0	552.73	309.81	2039.33
Mar 2017	23.55	532.92	898.21	517.98	1972.66	1147.47	0	552.88	272.31	1972.66
Mar 2018	23.55	453.08	856.59	284.84	1618.06	843.72	0.25	514.03	260.06	1618.06
Mar 2019	23.55	137.88	867.63	346.08	1375.14	593.73	0.28	513.37	267.76	1375.14
Mar 2020	23.55	35.63	708.56	204.85	972.59	506.21	0	173.17	293.21	972.59
Mar 2021	23.55	37.17	678.41	189.19	928.32	472.6	0.08	89.49	366.15	928.32
Mar 2022	23.55	19.86	689.92	193.25	926.58	445.82	0	80.51	400.25	926.58
Mar 2023	23.55	386.86	7.52	36.24	454.17	16.25	0	293.51	144.41	454.17
Mar 2024	23.55	392.11	10.29	34.54	460.49	63.41	0	293.52	103.56	460.49
Mar 2025	23.55	396.12	11.04	21.71	452.42	60.82	0	293.52	98.08	452.42
Mar 2026	23.55	397.35	11.87	22.36	455.13	57.62	0	309.71	87.8	455.13

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-16.68	-14.39	22.55	-8.51
Mar 2016	28.44	8.62	-35.07	1.98
Mar 2017	37.28	-48.08	6.24	-4.56
Mar 2018	7.17	78.31	-86.7	-1.22
Mar 2019	62.13	1.51	-60.25	3.39
Mar 2020	71.12	10.82	-83.03	-1.08
Mar 2021	-0.41	85.02	-82.28	2.33
Mar 2022	46.29	5.59	-55.47	-3.59
Mar 2023	397.43	180.97	-570.93	7.47
Mar 2024	97.63	-107.06	-0.51	-9.94
Mar 2025	2.36	2.94	-3.85	1.45
Mar 2026	11.57	-14.05	0.24	-2.24

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	79.96	69.13	62.11	57.94	56.41	67.40	86.74	78.67	246.73	101.41	82.32	108.70
Inventory Days	214.55	85.46	50.98	50.90	68.40	56.55	85.32	71.21	60.10	21.27	30.02	37.12
Days Payable	180.64	77.49	86.11	114.26	155.62	128.77	116.24	100.16	439.03	91.35	154.06	435.11
Cash Conversion Cycle	113.87	77.11	26.99	-5.42	-30.82	-4.82	55.82	49.72	-132.20	31.33	-41.72	-289.29
Working Capital Days	-327.69	-459.92	-555.87	-294.55	-395.82	-356.45	-178.42	-134.43	-640.97	1,135.23	1,530.01	2,541.15
ROCE %	-4.11%	-4.38%	-5.02%	-20.87%	-20.40%	-9.08%	0.34%	1.51%	-1.38%	-1.97%	1.58%	0.34%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BILCARE LTD. (BI)?

The reported market capitalisation for BILCARE LTD. (BI) is ₹215Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BI?

The current price shown for BILCARE LTD. (BI) on Fincrux is ₹93.2 with a 52-week high/low of ₹116/50.0.

What is the P/E ratio of BILCARE LTD. (BI)?

The stock P/E for BILCARE LTD. (BI) is 91.7 on Fincrux, with ROE at 0.01% and ROCE at 0.34%.

What were BI latest quarterly results?

For Jun 2026, BILCARE LTD. (BI) reported sales ₹1.94 Cr and net profit ₹1.04 Cr (figures in ₹ crore unless noted).

What are BI annual sales and net profit?

For TTM, BILCARE LTD. (BI) shows sales of ₹6.72 Cr and net profit of ₹-1.56 Cr on the Fincrux profit & loss statement.

Who owns BILCARE LTD. (BI)?

Latest shareholding for BILCARE LTD. (BI) on Fincrux: Promoters 30.01% (Jun 2026), FIIs 0.04% (Jun 2026), Public 69.94% (Jun 2026), No. of Shareholders 15,777% (Jun 2026).

Where can I find BILCARE LTD. (BI) financials?

BILCARE LTD. (BI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BI balance sheet and cash flow?

Yes. The BILCARE LTD. (BI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 16:55